BLACK FRIDAY

ADVFN

Celebrando 25 años Est 1999-2024

Ahorra hasta 60%* en Forex

1 año 40%, 2 años 40% y *3 años 60%

*Durante 3 años $1.035.00 solo $414.00

ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,048.07
0.82%
Dow Jones
44,799.65
-0.25%
US Dollar vs MXN
20.3864
0.00%
Brent Oil
71.625
-0.62%
Bitcoin
95,683.28
-1.62%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Fluidigm Corporation (FLDM) Cotización

Fluidigm Corporation

Fluidigm Corporation (FLDM)

Franklin International Multifactor Index ETF
3.71
0.00
( 0.00% )
Actualizado: 18:00:00
Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
3.71
Postura de Compra
3.69
Postura de Venta
4.03
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Capitalización de Mercado [m]
294.555M
Precio Anterior
3.71
Precio de Apertura
-
Hora
Última hora de negociación
-
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
-
Acciones en circulación
79,395,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-3.95
Beneficio por acción (BPA)
-0.94
turnover
106.34M
Beneficio neto
-74.66M

Acerca de Fluidigm Corporation

Fluidigm Corp manufactures life science tools focused on the analysis of single cells and industrial applications of genomics. These tools are based on microfluidics and mass cytometry technologies. It sells instruments and consumables, including integrated fluidic circuits, assays, and reagents. Sl... Fluidigm Corp manufactures life science tools focused on the analysis of single cells and industrial applications of genomics. These tools are based on microfluidics and mass cytometry technologies. It sells instruments and consumables, including integrated fluidic circuits, assays, and reagents. Slightly more than half of the firm's revenue comes from the sale of Consumables. Fluidigm primarily sells its products to academic institutions, clinical laboratories, and biopharmaceutical companies. The majority of revenue is generated in the United States followed by EMEA and Asia-Pacific. Mostrar más

Sector
Lab Analytical Instruments
Industria
Lab Analytical Instruments
Sitio web
www.fluidigm.com
Sede
Wilmington, Delaware, USA
Fundado
-

FLDM Últimas noticias

Más noticias

Fluidigm Completes $250 Million Strategic Capital Infusion and Changes Name to Standard BioTools Inc.

New Trading Symbol (NASDAQ:LAB) Expected to be Effective April 6, 2022 Appoints New Management Team and Additional Board Members with Significant Experience to Reinvigorate Growth and Enhance...

04 Abril 2022
GlobeNewswire Inc.

Fluidigm Stockholders Approve $250 Million Strategic Capital Infusion

SOUTH SAN FRANCISCO, Calif., April 01, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM) today announced that its stockholders have voted to approve all of the proposals related to the...

01 Abril 2022
GlobeNewswire Inc.

Fluidigm Announces Support Agreement with Caligan Partners Related to $250 Million Strategic Capital Infusion by Casdin Capital and Viking Global

Caligan Partners to Vote “FOR” Casdin and Viking Transaction and All Other Fluidigm Proposals at the Special Meeting to be Reconvened on April 1, 2022 Fluidigm Board to Appoint Frank Witney, a...

29 Marzo 2022
GlobeNewswire Inc.

Fluidigm Highlights the Strategic Capital Infusion by Casdin Capital and Viking Global as the Only Actionable Financing Solution

Company Urges ALL Stockholders to Vote “FOR” the Proposals at the Special Meeting Parties to Terminate the Purchase Agreements if Stockholder Approval is Not Received on April 1 SOUTH SAN...

28 Marzo 2022
GlobeNewswire Inc.

Fluidigm Adjourns Special Meeting of Stockholders Until April 1, 2022

SOUTH SAN FRANCISCO, Calif., March 25, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that it convened and then adjourned, without conducting any other business, the...

25 Marzo 2022
GlobeNewswire Inc.

Fluidigm Urges Stockholders to Vote “FOR” ALL Proposals Related to $250 Million Strategic Capital Infusion TODAY

SOUTH SAN FRANCISCO, Calif., March 21, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today urged Fluidigm stockholders to vote “FOR” ALL proposals related to the previously...

21 Marzo 2022
GlobeNewswire Inc.

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Fluidigm Stockholders Vote “FOR” ALL Proposals Related to $250 Million Strategic Capital Infusion

SOUTH SAN FRANCISCO, Calif., March 17, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), today announced that leading independent proxy advisory firms Institutional Shareholder...

17 Marzo 2022
GlobeNewswire Inc.

Fluidigm Announces Fourth Quarter and Full Year 2021 Financial Results 

SOUTH SAN FRANCISCO, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq: FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...

17 Febrero 2022
GlobeNewswire Inc.

Fluidigm Announces Collaboration Agreement with the Abu Dhabi Stem Cells Center to Accelerate Imaging Mass Cytometry in Development of Targeted Stem Cell Therapies

SOUTH SAN FRANCISCO, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq: FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...

17 Febrero 2022
GlobeNewswire Inc.

Fluidigm Files Preliminary Proxy Statement in Connection with Proposed Strategic Capital Infusion from Casdin Capital and Viking Global Investors

SOUTH SAN FRANCISCO, Calif., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM) today filed with the U.S. Securities and Exchange Commission (the “SEC”) a preliminary proxy...

14 Febrero 2022
GlobeNewswire Inc.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
SNTISenti Biosciences Inc
US$ 12.23
(466.20%)
112.59M
PPBTPurple Biotech Ltd
US$ 8.8624
(164.15%)
40.56M
SMCXDefiance Daily Target 2X Long SMCI ETF
US$ 81.455
(60.95%)
5.16M
FOSLFossil Group Inc
US$ 2.265
(55.14%)
24.16M
NVCRNovoCure Ltd
US$ 29.52
(47.31%)
8.22M
MONDMondee Holdings Inc
US$ 0.3885
(-45.30%)
1.98M
JYDJayud Global Logistics Ltd
US$ 0.7999
(-27.94%)
267.51k
QMCOQuantum Corporation
US$ 13.0601
(-24.99%)
2.25M
FOXXFoxx Development Holdings Inc
US$ 3.57
(-24.68%)
14.17k
SDOTSadot Group Inc
US$ 4.01
(-23.62%)
480.5k
SMCISuper Micro Computer Inc
US$ 42.66
(30.70%)
200.54M
XTIAXTI Aerospace Inc
US$ 0.0467
(4.01%)
163.51M
SNTISenti Biosciences Inc
US$ 12.23
(466.20%)
112.59M
RGTIRigetti Computing Inc
US$ 3.015
(-1.15%)
112.33M
NVDANVIDIA Corporation
US$ 138.825
(0.42%)
101.4M

FLDM Discussion

Ver más
manysevens manysevens 3 años hace
FLDM bot this 30 min chart today..

👍️0
Eggplant Eggplant 3 años hace
No. I think they are in deep doo doo. They just held their Q3 conference call, and took ZERO questions. What's that about? I think that level of silence speaks volumes. It looks like they are burning more than $10m of cash a quarter, with only $30m of cash remaining - but it's really only $20m if you net out the $10m of cash borrowed from Silicon Valley Bank term loan during the quarter. The working capital #'s are starting to look a bit strange: sales down, and A/R down commensurately, BUT Inventories UP, and A/P UP! It sure looks like they are stretching their payables. Who wants to do the A/P days calculation? Who wants to read the SVB loan agreement to see if covenants were tripped, or will be shortly?

On 7/27/21 Bloomberg reported that FLDM was working with an advisor and speaking to potential buyers of the company. That was 3 months ago, and: nothing. So today they announce a "Strategic Review . . . to maximize shareholder value". This looks like the trajectory of a distressed company, doesn't it?
👍️0
LongTimeObserver LongTimeObserver 4 años hace
$FLDM Back from the dead?
👍️0
LongTimeObserver LongTimeObserver 4 años hace
Pffft! $FLDM
👍️0
Atlanta1 Atlanta1 4 años hace
06:28
$FLDM
Fluidigm: Trump Administration provides saliva test at surge testing site in Waco, TX (6.75)
"Starting today, communities that are part of the federal surge testing effort for COVID-19, supported by the Trump Administration, have a new option: a test that uses samples of saliva collected by spitting into a sterile container. Made by Fluidigm Corporation and supported in part by the National Institutes of Health (NIH), the easy-to-use saliva test detects SARS-CoV-2, the virus that causes COVID-19, on a molecular level using a microfluidics platform. The accuracy of the test is comparable to other molecular-level tests of nasal swab samples, according to a clinical study conducted by the manufacturer. The U.S. Department of Health and Human Services (HHS) has traditionally provided nasal swab tests from other manufacturers to surge testing sites, which remain a choice for community officials."

https://www.hhs.gov/about/news/2020/10/16/trump-administration-provides-saliva-test-at-surge-testing-site-in-waco-tx.html
👍️0
Ckasper Ckasper 4 años hace
Don’t want to jinx it, but currently the stock is up 90%. Hope that means we’ll see a big gap opening tomorrow.
👍️0
Ckasper Ckasper 4 años hace
Does anybody know, when they are expecting the NHI approval and what is still open regarding the approval?
👍️0
lakingsphan0427 lakingsphan0427 4 años hace
The retarded Newscum of Khalifhurnia should do the same..

Patience is the key here..
👍️0
Hole shot King Hole shot King 4 años hace
Fluidigm Corporation (Nasdaq: $FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced progress on the Company’s Rapid Acceleration of Diagnostics (RADx) project.

https://ih.advfn.com/stock-market/NASDAQ/fluidigm-FLDM/stock-news/83214731/fluidigm-achieves-initial-milestone-under-nih-rapi
👍️0
Hole shot King Hole shot King 4 años hace
8K Item 8.01. Other Events.



From August 13, 2020 through September 3, 2020, Fluidigm Corporation (the “Company”) sold a total of 2,479,517 shares of its common stock for aggregate gross proceeds of approximately $20.9 million before commissions and offering expenses under its previously announced “at-the-market” equity offering program. The sales were completed pursuant to the Open Market Sale AgreementSM with Jefferies LLC dated as of March 4, 2020, which the Company filed as an exhibit to a Current Report on Form 8-K filed with the Securities and Exchange Commission on March 5, 2020.


https://ih.advfn.com/stock-market/NASDAQ/fluidigm-FLDM/stock-news/83213327/current-report-filing-8-k
👍️0
Ckasper Ckasper 4 años hace
NEWS OUT.
FLDM fulfills first step of NHI requirements.
👍️0
Hole shot King Hole shot King 4 años hace
The Law Offices of Frank R. Cruz Announces Investigation of Fluidigm Corporation (FLDM) on Behalf of Investors $FLDM https://newsfilter.io/a/0a76fc698a3e38b64c511d5e5683326e
👍️0
Hole shot King Hole shot King 4 años hace
$FLDM should have a good bounce
👍️0
Ckasper Ckasper 4 años hace
Keep it coming. Gotta be patient
👍️0
Hole shot King Hole shot King 4 años hace
$FLDM Gov of Missouri is working in the "coming weeks" to roll out the saliva based test to all Missouri citizens
👍️0
Hole shot King Hole shot King 4 años hace
$FLDM Governor to talk saliva-based COVID-19 test https://www.newspressnow.com/news/regional_news/central_missouri/governor-to-talk-saliva-based-covid-19-test/article_aa493c13-9d63-561b-a78c-e66218ec79e4.html?utm_medium=social&utm_source=twitter&utm_campaign=user-share via @newspressnow
👍️0
Ckasper Ckasper 4 años hace
Quick testing is still highly demanded. Especially with schools starting now.
👍️0
jonsmile jonsmile 4 años hace
Not sure it might be over it’s all about the cure now
👍️0
Ckasper Ckasper 4 años hace
Agree. That’s why I’m saying it’s going up from here.
👍️0
jonsmile jonsmile 4 años hace
This entire sector has been down

OPK as well
👍️0
Ckasper Ckasper 4 años hace
You here for short gains? That streak would be over now ;)
👍️0
jonsmile jonsmile 4 años hace
LOL counting those chickens I see
👍️0
Ckasper Ckasper 4 años hace
For now
👍️0
jonsmile jonsmile 4 años hace
But it’s red LOL
👍️0
Ckasper Ckasper 4 años hace
Today is the turnaround. First Green Day in a week. Up from here.
👍️0
Ckasper Ckasper 4 años hace
They’ll have to bring out news soon. Implementation in colleges and schools would be the perfect news.
👍️0
lakingsphan0427 lakingsphan0427 4 años hace
Added a few more here..
👍️0
rstar rstar 4 años hace
NIH grant monies and full approval coming next i think- also usage data will hopefully show detection earlier than other tests and greater accuracy $FLDM
👍️0
Ckasper Ckasper 4 años hace
It’ll jump next week again, if they bring out an official statement.
👍️0
Hole shot King Hole shot King 4 años hace
$FLDM

https://twitter.com/DARPA/status/1299367154580627459

👍️0
Hole shot King Hole shot King 4 años hace
$FLDM Interview on Washington University's new Saliva COVID test

Rich Head, MS, Director, Genome Technology Access Center,
@GenomeInstitute
, discusses Fluidigm’s FDA authorization of the new co-developed extraction-free saliva test, run on Fluidigm® Biomark™ HD microfluidics platform, with Fox2 News in St. Louis.


https://twitter.com/fluidigm/status/1299752445237624839


👍️0
lakingsphan0427 lakingsphan0427 4 años hace
Just added a few more today..
👍️0
Ckasper Ckasper 4 años hace
I like it. Great find
👍️0
Hole shot King Hole shot King 4 años hace
twitter https://www.marketbeat.com/instant-alerts/nasdaq-fldm-a-buy-or-sell-right-now-2020-08/

https://twitter.com/ZolmaxNews


https://zolmax.com/investing/fluidigm-nasdaqfldm-price-target-raised-to-16-00-at-ubs-group/4690037.html

$FLDM
👍️0
Ckasper Ckasper 4 años hace
Where did you see that?
👍️0
lakingsphan0427 lakingsphan0427 4 años hace
Sounds good to me..
👍️0
Hole shot King Hole shot King 4 años hace
Fluidigm $FLDM Price Target Raised to $16.00 at UBS Group
👍️0
Ckasper Ckasper 4 años hace
Hoping for a good post market move, so we can see some additional gain tomorrow.
👍️0
Inspector121 Inspector121 4 años hace
Never stop learning lessons. Priceless.
👍️0
Ckasper Ckasper 4 años hace
I rarely pick it right either, but this was pretty obvious. Thx for the kudos ;)
👍️0
Inspector121 Inspector121 4 años hace
Great call. Wish I had the knowledge to be able to see these things. Thanks
👍️0
Inspector121 Inspector121 4 años hace
Accuracy of that test is questionable. But BP can get away with it. Rigged system. Money talks and FDA listens.
👍️0
lakingsphan0427 lakingsphan0427 4 años hace
WHOA! my $7.65 buys this morning starts to look good..

$20 or better by end of year..
👍️0
Runners123 Runners123 4 años hace
That was a fleeting moment of hype, now a new test is approved that costs $5 and takes 5 minutes for results.
👍️0
Daddy Rick Daddy Rick 4 años hace
I'm at an avg. of $9.41 and feel good about it.

Thinking anything under $10.00 is a REALLY GREAT investment here. BWDIK lol
👍️0
sfast900 sfast900 4 años hace
Bittersweet, I was fine with 1000 shares at 10.
I guess 3200 is what it needed.
Try to get my shares NOW... LOL
👍️0
Ckasper Ckasper 4 años hace
It’ll bottom at 7.50. Then go back to around 9 in the afternoon.
👍️0
Daddy Rick Daddy Rick 4 años hace
Thank You.
👍️0
Inspector121 Inspector121 4 años hace
Abbott tests highly inaccurate.
👍️0
ib12u ib12u 4 años hace
Is this worth getting into? Looks like it took a fall at the opening..
👍️0

Su Consulta Reciente

NASDAQ
FLDM
Fluidigm
BIT
BERMIB
ETF
TSX
PWF.PR.E
Power Financial
LSE
1AMZ
1x Amzn
BIT
P166E6
BNP Paribas Issuance
BOV
NTCO3Q
NATURA ON
BIT
P1RHI3
BNP Paribas Issuance
BOV
TMOS34Q
Thermfischer DRN
BOV
TAEE4R
TAESA PN
BOV
V2RN34
Varonis Systems
TSXV
CTI.H
Caiterra International E...
LSE
SPOL
Ishr Msci Pol
AQEU
WOLV
Wolford
TG
2GB
2G energy
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados

BLACK FRIDAY

ADVFN

Celebrando 25 años Est 1999-2024

Ahorra hasta 60%* en Forex

1 año 40%, 2 años 40% y *3 años 60%

*Durante 3 años $1.035.00 solo $414.00